133 related articles for article (PubMed ID: 36629160)
21. Methyltransferase SMYD3 impairs hypoxia tolerance by augmenting hypoxia signaling independent of its enzymatic activity.
Wang Z; Chen X; Fan S; Zhu C; Deng H; Tang J; Sun X; Jia S; Liao Q; Xiao W; Liu X
J Biol Chem; 2022 Dec; 298(12):102633. PubMed ID: 36273580
[TBL] [Abstract][Full Text] [Related]
22. Alternative regulation of HIF-1α stability through Phosphorylation on Ser451.
Han HJ; Saeidi S; Kim SJ; Piao JY; Lim S; Guillen-Quispe YN; Choi BY; Surh YJ
Biochem Biophys Res Commun; 2021 Mar; 545():150-156. PubMed ID: 33550096
[TBL] [Abstract][Full Text] [Related]
23. Hypoxia inducible factor signaling in breast tumors controls spontaneous tumor dissemination in a site-specific manner.
Todd VM; Vecchi LA; Clements ME; Snow KP; Ontko CD; Himmel L; Pinelli C; Rafat M; Johnson RW
Commun Biol; 2021 Sep; 4(1):1122. PubMed ID: 34556788
[TBL] [Abstract][Full Text] [Related]
24. Immunophilin-ligands FK506 and CsA inhibit HIF1alpha expression by a VHL- and ubiquitin-independent mechanism.
Kong X; Lin Z; Caro J
FEBS Lett; 2006 Nov; 580(26):6182-6. PubMed ID: 17067582
[TBL] [Abstract][Full Text] [Related]
25. GPER-mediated stabilization of HIF-1α contributes to upregulated aerobic glycolysis in tamoxifen-resistant cells.
Zhang Y; Song Y; Ren S; Zhang M; Zhang Z; Fan S; Liu X; Peng X; Qi Q; Shen X; Chen Y
Oncogene; 2023 Jan; 42(3):184-197. PubMed ID: 36400971
[TBL] [Abstract][Full Text] [Related]
26. CHD1 and SPOP synergistically protect prostate epithelial cells from DNA damage.
Zhu Y; Wen J; Huang G; Mittlesteadt J; Wen X; Lu X
Prostate; 2021 Jan; 81(1):81-88. PubMed ID: 33022763
[TBL] [Abstract][Full Text] [Related]
27. Role of VHL, HIF1A and SDH on the expression of miR-210: Implications for tumoral pseudo-hypoxic fate.
Merlo A; Bernardo-Castiñeira C; Sáenz-de-Santa-María I; Pitiot AS; Balbín M; Astudillo A; Valdés N; Scola B; Del Toro R; Méndez-Ferrer S; Piruat JI; Suarez C; Chiara MD
Oncotarget; 2017 Jan; 8(4):6700-6717. PubMed ID: 28036268
[TBL] [Abstract][Full Text] [Related]
28. TCTP increases stability of hypoxia-inducible factor 1α by interaction with and degradation of the tumour suppressor VHL.
Chen K; Chen S; Huang C; Cheng H; Zhou R
Biol Cell; 2013 May; 105(5):208-218. PubMed ID: 23387829
[TBL] [Abstract][Full Text] [Related]
29. microRNA-222-Mediated VHL Downregulation Facilitates Retinoblastoma Chemoresistance by Increasing HIF1α Expression.
Li C; Zhao J; Sun W
Invest Ophthalmol Vis Sci; 2020 Aug; 61(10):9. PubMed ID: 32756923
[TBL] [Abstract][Full Text] [Related]
30. HDAC4 protein regulates HIF1α protein lysine acetylation and cancer cell response to hypoxia.
Geng H; Harvey CT; Pittsenbarger J; Liu Q; Beer TM; Xue C; Qian DZ
J Biol Chem; 2011 Nov; 286(44):38095-38102. PubMed ID: 21917920
[TBL] [Abstract][Full Text] [Related]
31. RUNX3 inhibits hypoxia-inducible factor-1α protein stability by interacting with prolyl hydroxylases in gastric cancer cells.
Lee SH; Bae SC; Kim KW; Lee YM
Oncogene; 2014 Mar; 33(11):1458-67. PubMed ID: 23542169
[TBL] [Abstract][Full Text] [Related]
32. Regulation of glucose metabolism by p62/SQSTM1 through HIF1α.
Chen K; Zeng J; Xiao H; Huang C; Hu J; Yao W; Yu G; Xiao W; Xu H; Ye Z
J Cell Sci; 2016 Feb; 129(4):817-30. PubMed ID: 26743088
[TBL] [Abstract][Full Text] [Related]
33. Formation of Renal Cysts and Tumors in Vhl/Trp53-Deficient Mice Requires HIF1α and HIF2α.
Schönenberger D; Harlander S; Rajski M; Jacobs RA; Lundby AK; Adlesic M; Hejhal T; Wild PJ; Lundby C; Frew IJ
Cancer Res; 2016 Apr; 76(7):2025-36. PubMed ID: 26759234
[TBL] [Abstract][Full Text] [Related]
34. Wogonin inhibits tumor angiogenesis via degradation of HIF-1α protein.
Song X; Yao J; Wang F; Zhou M; Zhou Y; Wang H; Wei L; Zhao L; Li Z; Lu N; Guo Q
Toxicol Appl Pharmacol; 2013 Sep; 271(2):144-55. PubMed ID: 23707765
[TBL] [Abstract][Full Text] [Related]
35. Src activates HIF-1α not through direct phosphorylation of HIF-1α specific prolyl-4 hydroxylase 2 but through activation of the NADPH oxidase/Rac pathway.
Lee HY; Lee T; Lee N; Yang EG; Lee C; Lee J; Moon EY; Ha J; Park H
Carcinogenesis; 2011 May; 32(5):703-12. PubMed ID: 21335603
[TBL] [Abstract][Full Text] [Related]
36. Carboxyl-terminal transactivation activity of hypoxia-inducible factor 1 alpha is governed by a von Hippel-Lindau protein-independent, hydroxylation-regulated association with p300/CBP.
Sang N; Fang J; Srinivas V; Leshchinsky I; Caro J
Mol Cell Biol; 2002 May; 22(9):2984-92. PubMed ID: 11940656
[TBL] [Abstract][Full Text] [Related]
37. Hypoxia-inducible factor 1alpha is regulated by the mammalian target of rapamycin (mTOR) via an mTOR signaling motif.
Land SC; Tee AR
J Biol Chem; 2007 Jul; 282(28):20534-43. PubMed ID: 17502379
[TBL] [Abstract][Full Text] [Related]
38. The LIMD1 protein bridges an association between the prolyl hydroxylases and VHL to repress HIF-1 activity.
Foxler DE; Bridge KS; James V; Webb TM; Mee M; Wong SC; Feng Y; Constantin-Teodosiu D; Petursdottir TE; Bjornsson J; Ingvarsson S; Ratcliffe PJ; Longmore GD; Sharp TV
Nat Cell Biol; 2012 Jan; 14(2):201-8. PubMed ID: 22286099
[TBL] [Abstract][Full Text] [Related]
39. Nitric oxide donor, (+/-)-S-nitroso-N-acetylpenicillamine, stabilizes transactive hypoxia-inducible factor-1alpha by inhibiting von Hippel-Lindau recruitment and asparagine hydroxylation.
Park YK; Ahn DR; Oh M; Lee T; Yang EG; Son M; Park H
Mol Pharmacol; 2008 Jul; 74(1):236-45. PubMed ID: 18426857
[TBL] [Abstract][Full Text] [Related]
40. HIF-1α Hydroxyprolines Modulate Oxygen-Dependent Protein Stability Via Single VHL Interface With Comparable Effect on Ubiquitination Rate.
He W; Batty-Stuart S; Lee JE; Ohh M
J Mol Biol; 2021 Nov; 433(22):167244. PubMed ID: 34537235
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
